Shanghai Haohai Biological Technology Co., Ltd. (HKG: 6826)

Shanghai Haohai Biological Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,667	2,741	2,545	2,901	3,093	3,223
Short-Term Investments	-	-	-	12.18	4.65	16.5
Trading Asset Securities	71.95	20.3	6.75	6.38	15.15	-
Cash & Short-Term Investments	2,739	2,761	2,551	2,919	3,112	3,239
Cash Growth	-3.80%	8.22%	-12.61%	-6.20%	-3.91%	121.99%
Accounts Receivable	336.21	327.86	381.53	375.21	340.75	390
Other Receivables	52.68	47.57	12.16	7	7	38.95
Receivables	388.9	375.43	393.69	382.21	347.75	428.95
Inventory	504.21	526.17	485.24	354.77	255.13	239.99
Other Current Assets	88.29	87.56	101.85	56.27	94.68	37.43
Total Current Assets	3,720	3,750	3,532	3,713	3,810	3,945
Property, Plant & Equipment	1,573	1,455	1,337	1,412	1,180	1,112
Long-Term Investments	612.43	607.1	671.44	625.35	455.5	297.96
Goodwill	422.83	413.02	411.2	406.9	385.49	333.49
Other Intangible Assets	741.13	729.07	783.53	613.4	404.33	430.61
Long-Term Deferred Tax Assets	53.7	53.12	59.32	49.36	26.19	18.39
Long-Term Deferred Charges	9.87	5.4	8.44	-	-	-
Other Long-Term Assets	83.33	92.19	89.07	130.93	36.85	14.26
Total Assets	7,242	7,105	6,892	6,950	6,299	6,152
Accounts Payable	64.96	55.11	54.53	46.26	28.03	36.79
Accrued Expenses	185.61	196.54	223.87	174.5	124.58	101.83
Short-Term Debt	26	10	5.31	48.78	78.69	5.3
Current Portion of Long-Term Debt	187.35	186.31	7.7	0.13	0.15	9.34
Current Portion of Leases	17.64	20.31	21.36	17.11	8.87	11.07
Current Income Taxes Payable	33.58	34.4	24.65	1.26	21.08	34.15
Current Unearned Revenue	168.17	124.69	83.51	107.42	80.98	45.08
Other Current Liabilities	125.03	88.58	90.32	91.82	91.38	116.41
Total Current Liabilities	808.33	715.95	511.27	487.27	433.76	359.97
Long-Term Debt	167.39	157.44	43.98	9.89	0.58	0.65
Long-Term Leases	25.8	33.88	39.9	29.61	19.79	23.35
Long-Term Unearned Revenue	14.69	13.63	5.5	9.4	3.54	3.6
Long-Term Deferred Tax Liabilities	164.58	161.66	163.51	157.91	102.28	110.95
Other Long-Term Liabilities	5.58	5.64	225.85	195.99	4.5	-
Total Liabilities	1,186	1,088	990.01	890.07	564.46	498.52
Common Stock	235.49	171.48	174.13	175.82	177.21	177.85
Additional Paid-In Capital	2,837	2,981	3,003	3,091	3,260	3,282
Retained Earnings	2,889	2,818	2,458	2,399	2,046	1,936
Treasury Stock	-178.06	-248.46	-74.04	-	-28.26	-
Comprensive Income & Other	-95.54	-71.45	-46.76	47.87	35.93	59.54
Total Common Equity	5,688	5,650	5,515	5,713	5,491	5,455
Minority Interest	367.65	367.23	387.77	346.83	243.49	198.57
Shareholders' Equity	6,056	6,017	5,902	6,060	5,734	5,653
Total Liabilities & Equity	7,242	7,105	6,892	6,950	6,299	6,152
Total Debt	424.18	407.95	118.26	105.51	108.08	49.71
Net Cash (Debt)	2,315	2,353	2,433	2,814	3,004	3,189
Net Cash Growth	-11.54%	-3.29%	-13.53%	-6.34%	-5.80%	124.21%
Net Cash Per Share	7.01	7.04	7.15	8.15	8.65	9.98
Filing Date Shares Outstanding	232.98	233.57	239.78	246.15	247.27	248.98
Total Common Shares Outstanding	232.98	233.93	239.78	246.15	247.27	248.98
Working Capital	2,912	3,034	3,021	3,225	3,376	3,585
Book Value Per Share	24.42	24.15	23.00	23.21	22.21	21.91
Tangible Book Value	4,524	4,508	4,320	4,693	4,701	4,691
Tangible Book Value Per Share	19.42	19.27	18.02	19.07	19.01	18.84
Land	-	-	-	359.38	273.19	262.89
Buildings	379.37	365.66	346.25	-	-	-
Machinery	902.98	977.35	890.64	750.86	517.33	491.99
Construction In Progress	780.61	635.61	518.98	369.57	441.01	356.51
Leasehold Improvements	-	-	-	139.83	88.48	75.96

Source: S&P Capital IQ. Standard template. Financial Sources.